Cinthia E Jannes Selected Research

Cinthia E Jannes Research Topics

14	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 03/2022 - 11/2014
6	Cardiovascular Diseases (Cardiovascular Disease) 03/2021 - 01/2017
4	Hypertension (High Blood Pressure) 10/2018 - 09/2015
3	Atherosclerosis 01/2021 - 12/2019
3	Dyslipidemias (Dyslipidemia) 01/2021 - 11/2014
2	Inflammation (Inflammations) 01/2021 - 12/2019
2	Myocardial Infarction 01/2019 - 10/2018
2	Xanthomatosis (Xanthoma) 01/2017 - 01/2017
1	Homozygous Familial Hypercholesterolemia 10/2020
1	Unstable Angina 01/2019
1	Stroke (Strokes) 01/2019
1	Inborn Genetic Diseases (Disease, Hereditary) 10/2018
1	Obesity 10/2018
1	Arcus Senilis 01/2017
1	Coronary Disease (Coronary Heart Disease) 09/2015

7	oxidized low density lipoproteinIBA 03/2022 - 01/2017
5	LDL CholesterolIBA 03/2022 - 10/2020
5	LipidsIBA 03/2022 - 11/2014
3	CalciumIBA 01/2020 - 01/2017
3	CholesterolIBA 10/2018 - 09/2015
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2019
1	Adenosine Monophosphate (AMP)IBA 01/2022
1	LDL Receptors (LDL Receptor)IBA 03/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	3' Untranslated Regions (3' UTR)IBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 11/2018
1	omega-Chloroacetophenone (Mace)IBA 10/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017
1	Myosin Light Chains (Myosin Essential Light Chain)IBA 11/2014
1	Proteins (Proteins, Gene)FDA Link 11/2014

3	Therapeutics 01/2020 - 11/2014
2	Mediterranean Diet 01/2021 - 12/2019
1	Myocardial Revascularization 01/2019